Ali Sheikh, DO
Cardiovascular Disease · Lansing, MINPI 1013148048
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 67.0% of it on its own, with 22 other manufacturers making up the rest.
Across 176 payments — averaging $79.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Biosense Webster, Inc.$1K
- Abbott$900
- Boston Scientific$727
- Medical Device Business Services, Inc.$540
- Acutus Medical, Inc.$282
- plus $1K from 17 others
Across 47 payments — averaging $4074.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$185K
- Impulse Dynamics (USA) Inc.$7K
What the payments were for
- Speaking & faculty fees$2,10015%
- Travel & lodging$6,47846%
- Food & beverage$5,29038%
- Education$1101%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 95 | $9,372 |
| Biosense Webster, Inc. | 10 | $1,062 |
| Abbott | 8 | $900 |
| Boston Scientific | 14 | $727 |
| Medical Device Business Services, Inc. | 3 | $540 |
| Acutus Medical, Inc. | 9 | $282 |
| Biotronik Inc. | 4 | $223 |
| Atricure, Inc. | 4 | $195 |
| E.r. Squibb & Sons, L.L.C. | 7 | $147 |
| Angiodynamics, Inc. | 2 | $142 |
| Impulse Dynamics (USA) Inc. | 4 | $73 |
| Johnson & Johnson | 3 | $52 |
| Cardiva Medical, Inc. | 1 | $44 |
| AstraZeneca | 2 | $38 |
| Pfizer | 2 | $38 |
| Lundbeck LLC | 1 | $23 |
| Edwards Lifesciences | 1 | $23 |
| Bridgebio Pharma, Inc. | 1 | $22 |
| Novartis | 1 | $17 |
| Amgen | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $15 |
| Bayer | 1 | $15 |
| Irhythm Technologies, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$1,408
- Agilis NxT EP Introducer$491
- EVERA MRI XT DR SURESCAN$401
- Claria MRI$184
- COBALT DR MRI SURESCAN$136
- Micra$134
- EMBLEM MRI S-ICD$129
- AngioVac$119
- ENSITE PRECISION$111
- ENSITE$111
- Acticor 7 VR-T DX$111
How this compares
$13,978 in reported general payments places this provider in the 80th percentile of 760 cardiovascular disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 85 | $93,885 |
| XareltoRivaroxaban | 20 | $27,406 |
| MultaqDronedarone Hcl | 16 | $17,248 |
| Dofetilide | 26 | $5,705 |
| SotalolSotalol Hcl | 31 | $1,536 |
| Flecainide Acetate | 39 | $1,402 |
| Metoprolol Succinate | 60 | $1,294 |
| Amiodarone Hcl | 26 | $1,051 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $473 |
| Losartan Potassium | 15 | $276 |
| Metoprolol Tartrate | 18 | $104 |
| Furosemide | 15 | $87 |
| Amlodipine Besylate | 12 | $72 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $38 | $93,88585 claims |
| Johnson & JohnsonXarelto | $52 | $27,40620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 760 cardiovascular disease providers in Michigan.
Other cardiovascular disease in Lansing
- David StroblLansing$445K
- Chad LinkLansing$315K
- Marschall RungeAnn Arbor$1.8M
- Jihad MustaphaGrand Rapids$1.6M
- Vallerie McLaughlinAnn Arbor$947K
- Pedro Villablanca SpinettoDetroit$620K
- Stanley ChetcutiAnn Arbor$573K
- David HainesRoyal Oak$492K
- Steven AlmanyTroy$471K
- Herman KadoSouthfield$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.